Erlocip contains erlotinib and belongs to a class of medications called kinase inhibitors.
Erlocip is used for the treatment of non-small cell lung cancer. Erlocip is used in combination with gemcitabine for the treatment of pancreatic cancer that has spread to nearby tissues or to other parts of the body.
Mechanism of Action: Erlocip works by blocking the action of an abnormal protein that slows the growth of cancer cells. This helps slow or stop the spread of cancer cells.
Supplied as: Erlocip is available as 150mg tablets.
Overdose: Symptoms of overdose associated with Erlocip may include diarrhea and rash.
All Trade Leads / Offers / Products / Company Profiles / Images and other user-posted contents are posted by the user and Middle East B2B Directory and TradeHolding.com B2B Network shall not be held liable for any such content. However, TradeHolding.com B2B Network respects the intellectual property, copyright, trademark, trade secret or any other personal or proprietary third party rights and expects the same from others. For concerns, please contact us.